Symbols

STE

STERIS·NYSE

--(--)

STE fundamentals

STE Q3 2026 Earnings

STERIS (STE) released its earnings on Feb 4, 2026: revenue was 1.50B (YoY +6.87%), beat estimates; EPS was 2.53 (YoY +9.05%), missed estimates.

Revenue / YoY

1.50B

+6.87%

EPS / YoY

2.53

+9.05%

Report date

Feb 4, 2026

STE Earnings Call Summary for Q3,2026

Revenue Growth: 9% as-reported, 8% organic driven by price/volume.
Margin Challenges: Gross (-70bps), EBIT (-40bps) due to tariffs.
Segment Strength: AST services +9%, Life Sciences consumables +11%.
Tariff Impact: $55M annualized, $16M Q3.
Q4 Caution: Tough comps, but resilient capital spending.
Long-Term Outlook: Positive macro trends, disciplined M&A.

Earnings

EPS

Revenue

Revenue & Expenses

STE has released its 2026 Q3 earnings report, with revenue of 1.50B, reflecting a YoY change of 9.16%, and net profit of 194.30M, showing a YoY change of 12.12%. The Sankey diagram below clearly presents STE's revenue sources and cost distribution.

Key Indicators

STERIS (STE) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

STERIS (STE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

STERIS (STE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

STERIS (STE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown